Showing results (291-300 of 316) with videos related to
Sort By:
Pageof 32
Journal of Immunology (Baltimore, Md. : 1950)|July 19, 2011
Uveitis-associated epitopes of retinal antigens are pathogenic in the humanized mouse model of uveitis and identify autoaggressive T cellsMary J Mattapallil, Phyllis B Silver, Joseph J Mattapallil, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 4, 2021
Leukocyte chemotactic receptor Fpr1 protects against aging-related posterior subcapsular cataract formationJi-Liang Gao, Joseph D Weaver, Jingsheng Tuo, et al.Blood|September 13, 2011
Mouse models of MYH9-related disease: mutations in nonmuscle myosin II-AYingfan Zhang, Mary Anne Conti, Daniela Malide, et al.Plos One|May 1, 2014
Interleukin-17 retinotoxicity is prevented by gene transfer of a soluble interleukin-17 receptor acting as a cytokine blocker: implications for age-related macular degenerationDaniel Ardeljan, Yujuan Wang, Stanley Park, et al.Journal of Autoimmunity|July 2, 2013
Breakdown of immune privilege and spontaneous autoimmunity in mice expressing a transgenic T cell receptor specific for a retinal autoantigenReiko Horai, Phyllis B Silver, Jun Chen, et al.The Journal of Clinical Investigation|April 17, 2003
A humanized model of experimental autoimmune uveitis in HLA class II transgenic miceGiuseppina Pennesi, Mary J Mattapallil, Shu-Hui Sun, et al.Proceedings of the National Academy of Sciences of the United States of America|June 5, 2008
Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunityDouglas C Palmer, Chi-Chao Chan, Luca Gattinoni, et al.Investigative Ophthalmology & Visual Science|August 29, 2007
Analysis of ocular hypopigmentation in Rab38cht/cht miceBrian P Brooks, Denise M Larson, Chi-Chao Chan, et al.Cancer Research|January 6, 2018
Deletion of the von Hippel-Lindau Gene in Hemangioblasts Causes Hemangioblastoma-like Lesions in Murine RetinaHerui Wang, Matthew J Shepard, Chao Zhang, et al.Ocular Immunology and Inflammation|June 15, 2007
A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behçet's diseaseRonald R Buggage, Grace Levy-Clarke, Hatice N Sen, et al.Pageof 32